Phlebology OnlineFirst, published on May 18, 2015 A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency Eberhard Rabe1, Stefania Ballarini2 and Lorenz Lehr2, on behalf of the Doxium EDX09/01 Study Group 1Department of Dermatology, Rheinische Friedrich-Wilhelms University, Bonn, Germany 2Vifor Pharma, Meyrin, Switzerland Abstract Objective To show the superiority of 500 mg calcium dobesilate vs. placebo in reduction ...
Read More

Phlebology, 2011; 26:162–168 Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial E Rabe1, K A Jaeger2, M Bulitta3 and F Pannier4 1Department of Dermatology, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany; 2Department of Angiology, University Hospital Basel, Petersgraben 4, CH- 4031 Basel, Switzerland; 3CRM Biometrics GmbH, Marie-Curie-Str. 2, D-53359 Rheinbach, Germany; 4Department of Dermatology, University of Cologne, Kerpener Str 62, 50937 Koln, Germany ...
Read More

Angiology , Volume 55, Number 2, 2004 Calcium Dobesilate for Chronic Venous Insufficiency: A Systematic Review Agustín Ciapponi, MD,1 Enrique Laffaire, MD, 2and Marta Roqué, BSc, 3Buenos Aires, Argentina and Barcelona, Spain From the 1Family and Preventive Medicine Division, Hospital Italiano de Buenos Aires; the 2Programa de Efectividad Clínica, Hospital Italiano de Buenos Aires, Universidad de Buenos Aires, Argentina; and the 3Department of Clinic Epidemiology and Public Health, Hospital de ...
Read More